Results 251 to 260 of about 607,787 (304)

Pediatric Use of Off-Label Medicines and Nonevidence-Based Supplements for COVID-19: Findings From the 2015 Pelotas Birth Cohort Study (Brazil). [PDF]

Pharmacoepidemiol Drug Saf
Bertoldi AD, Guimarães FS, Boing AC, Silveira MPT, Hallal PC, da Silveira MF.   +5 more
europepmc   +1 more source

Social Marketing Strategies in the Pharmaceutical Industry, Characteristics and Impact; a scoping review. [PDF]

Farm Comunitarios
Carreño-Patiño LB, Menco-Goenaga EI, Cepeda-Obregón RD.   +2 more
europepmc   +1 more source

Strengthening access to antihypertensive medicines through HEARTS in the Americas: the Grenada experience. [PDF]

Rev Panam Salud Publica
Renaud-Thomas KA, Mark L, Isaac C, Malcolm T, Charles S.   +4 more
europepmc   +1 more source

Transforming pediatric oncology in Ecuador through the Global Platform for Access to Childhood Cancer Medicines. [PDF]

Rev Panam Salud Publica
Lissette M, Vásquez L, Guerrero C, Villacrés N, Antiporta DA, Lavayen M, Meza K, Solís P, Santana D, Solís R, Del Carmen Trujillo M, Solórzano G, Sánchez L, Calle D, Bonilla D, Sanchez G, Espin L, Guerrero E, Cedeño R, Jimenez S, Morales A, Kasper T, Millan S, Alcocer P, Lim C, Maza M, Luciani S, Rodríguez-Galindo C, Quezada S.   +28 more
europepmc   +1 more source

A natural language processing approach to determine whether streamlined health technology assessment for multi-indication medicines is feasible. [PDF]

PLOS Digit Health
Luc I, Carter D, Bergman E, Westman G, Merlin T.   +4 more
europepmc   +1 more source

Guidelines for safe and effective management and use of point of care testing in primary and community care

, 2010
Irish Medicines Board (IMB)
core